These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
733 related articles for article (PubMed ID: 18492291)
1. Evidence for efficient phosphorylation of EGFR and rapid endocytosis of phosphorylated EGFR via the early/late endocytic pathway in a gefitinib-sensitive non-small cell lung cancer cell line. Nishimura Y; Yoshioka K; Bereczky B; Itoh K Mol Cancer; 2008 May; 7():42. PubMed ID: 18492291 [TBL] [Abstract][Full Text] [Related]
2. The EGFR inhibitor gefitinib suppresses ligand-stimulated endocytosis of EGFR via the early/late endocytic pathway in non-small cell lung cancer cell lines. Nishimura Y; Bereczky B; Ono M Histochem Cell Biol; 2007 May; 127(5):541-53. PubMed ID: 17361439 [TBL] [Abstract][Full Text] [Related]
3. Silencing of SNX1 by siRNA stimulates the ligand-induced endocytosis of EGFR and increases EGFR phosphorylation in gefitinib-resistant human lung cancer cell lines. Nishimura Y; Takiguchi S; Yoshioka K; Nakabeppu Y; Itoh K Int J Oncol; 2012 Oct; 41(4):1520-30. PubMed ID: 22859339 [TBL] [Abstract][Full Text] [Related]
4. EGF‑stimulated AKT activation is mediated by EGFR recycling via an early endocytic pathway in a gefitinib‑resistant human lung cancer cell line. Nishimura Y; Takiguchi S; Ito S; Itoh K Int J Oncol; 2015 Apr; 46(4):1721-9. PubMed ID: 25653196 [TBL] [Abstract][Full Text] [Related]
5. Evidence that depletion of the sorting nexin 1 by siRNA promotes HGF-induced MET endocytosis and MET phosphorylation in a gefitinib-resistant human lung cancer cell line. Nishimura Y; Takiguchi S; Ito S; Itoh K Int J Oncol; 2014 Feb; 44(2):412-26. PubMed ID: 24297483 [TBL] [Abstract][Full Text] [Related]
6. A novel role of Rho-kinase in the regulation of ligand-induced phosphorylated EGFR endocytosis via the early/late endocytic pathway in human fibrosarcoma cells. Nishimura Y; Bereczky B; Yoshioka K; Taniguchi S; Itoh K J Mol Histol; 2011 Oct; 42(5):427-42. PubMed ID: 21847509 [TBL] [Abstract][Full Text] [Related]
7. Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation. Ono M; Hirata A; Kometani T; Miyagawa M; Ueda S; Kinoshita H; Fujii T; Kuwano M Mol Cancer Ther; 2004 Apr; 3(4):465-72. PubMed ID: 15078990 [TBL] [Abstract][Full Text] [Related]
8. Ephedrae herba stimulates hepatocyte growth factor-induced MET endocytosis and downregulation via early/late endocytic pathways in gefitinib-resistant human lung cancer cells. Nishimura Y; Hyuga S; Takiguchi S; Hyuga M; Itoh K; Hanawa T Int J Oncol; 2016 May; 48(5):1895-906. PubMed ID: 26983447 [TBL] [Abstract][Full Text] [Related]
9. TIP30 overcomes gefitinib resistance by regulating cytoplasmic and nuclear EGFR signaling in non-small-cell lung cancer. Shuai S; Liao X; Wang H; Liu L; Mei S; Cao J; Wang S Cancer Sci; 2021 Oct; 112(10):4139-4150. PubMed ID: 34058054 [TBL] [Abstract][Full Text] [Related]
10. Involvement of SNX1 in regulating EGFR endocytosis in a gefitinib-resistant NSCLC cell lines. Nishimura Y; Itoh K Cancer Drug Resist; 2019; 2(3):539-549. PubMed ID: 35582586 [TBL] [Abstract][Full Text] [Related]
12. LIM kinase 1: evidence for a role in the regulation of intracellular vesicle trafficking of lysosomes and endosomes in human breast cancer cells. Nishimura Y; Yoshioka K; Bernard O; Himeno M; Itoh K Eur J Cell Biol; 2004 Aug; 83(7):369-80. PubMed ID: 15503860 [TBL] [Abstract][Full Text] [Related]
13. Re-localization of activated EGF receptor and its signal transducers to multivesicular compartments downstream of early endosomes in response to EGF. Oksvold MP; Skarpen E; Wierød L; Paulsen RE; Huitfeldt HS Eur J Cell Biol; 2001 Apr; 80(4):285-94. PubMed ID: 11370743 [TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical localization of Shc and activated EGF receptor in early endosomes after EGF stimulation of HeLa cells. Oksvold MP; Skarpen E; Lindeman B; Roos N; Huitfeldt HS J Histochem Cytochem; 2000 Jan; 48(1):21-33. PubMed ID: 10653583 [TBL] [Abstract][Full Text] [Related]
15. Engagement of the small GTPase Rab31 protein and its effector, early endosome antigen 1, is important for trafficking of the ligand-bound epidermal growth factor receptor from the early to the late endosome. Chua CE; Tang BL J Biol Chem; 2014 May; 289(18):12375-89. PubMed ID: 24644286 [TBL] [Abstract][Full Text] [Related]
16. EGF receptor lysosomal degradation is delayed in the cells stimulated with EGF-Quantum dot bioconjugate but earlier key events of endocytic degradative pathway are similar to that of native EGF. Salova AV; Belyaeva TN; Leontieva EA; Kornilova ES Oncotarget; 2017 Jul; 8(27):44335-44350. PubMed ID: 28574831 [TBL] [Abstract][Full Text] [Related]
17. PLAUR Confers Resistance to Gefitinib Through EGFR/P-AKT/Survivin Signaling Pathway. Zhou J; Kwak KJ; Wu Z; Yang D; Li J; Chang M; Song Y; Zeng H; Lee LJ; Hu J; Bai C Cell Physiol Biochem; 2018; 47(5):1909-1924. PubMed ID: 29961070 [TBL] [Abstract][Full Text] [Related]
18. Hypoxia induces gefitinib resistance in non-small-cell lung cancer with both mutant and wild-type epidermal growth factor receptors. Minakata K; Takahashi F; Nara T; Hashimoto M; Tajima K; Murakami A; Nurwidya F; Yae S; Koizumi F; Moriyama H; Seyama K; Nishio K; Takahashi K Cancer Sci; 2012 Nov; 103(11):1946-54. PubMed ID: 22863020 [TBL] [Abstract][Full Text] [Related]
19. Chlorpromazine cooperatively induces apoptosis with tyrosine kinase inhibitors in EGFR-mutated lung cancer cell lines and restores the sensitivity to gefitinib in T790M-harboring resistant cells. Fujiwara R; Taniguchi Y; Rai S; Iwata Y; Fujii A; Fujimoto K; Kumode T; Serizawa K; Morita Y; Espinoza JL; Tanaka H; Hanamoto H; Matsumura I Biochem Biophys Res Commun; 2022 Oct; 626():156-166. PubMed ID: 35994825 [TBL] [Abstract][Full Text] [Related]
20. rab7 activity affects epidermal growth factor:epidermal growth factor receptor degradation by regulating endocytic trafficking from the late endosome. Ceresa BP; Bahr SJ J Biol Chem; 2006 Jan; 281(2):1099-106. PubMed ID: 16282324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]